Sorafenib inhibits therapeutic induction of necroptosis in acute leukemia cells

Induction of necroptosis has emerged as an alternative approach to trigger programmed cell death, in particular in apoptosis-resistant cancer cells. Recent evidence suggests that kinase inhibitors targeting oncogenic B-RAF can also affect Receptor-interacting serine/threonine-protein kinase (RIP)1 a...

Descripción completa

Detalles Bibliográficos
Autores principales: Feldmann, Friederike, Schenk, Barbara, Martens, Sofie, Vandenabeele, Peter, Fulda, Simone
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620249/
https://www.ncbi.nlm.nih.gov/pubmed/28978109
http://dx.doi.org/10.18632/oncotarget.19919

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620249/
https://www.ncbi.nlm.nih.gov/pubmed/28978109
http://dx.doi.org/10.18632/oncotarget.19919

Ejemplares similares